Biohaven
-
Biohaven (BHVN) Stock Plummets After Pausing Midstage Seizure Treatment Study Due to Safety Concerns and FDA Toxicity Assessment Requirement
Biohaven (BHVN) stock plummeted Thursday after the company paused enrollment in a midstage study of its seizure treatment opakalim due to safety concerns. The Food and Drug Administration (FDA) is now
-
RBC Downgrades Biohaven to "Sector Perform," Lowers Price Target to $19; Biohaven Shares Down 1.9% in Pre-market Trading
Biohaven Pharmaceutical (NYSE:BHVN) shares fell 1.9% in premarket trading after RBC Capital downgraded the stock to "Sector Perform" from "Outperform" and lowered its price target to $19 from $23. RBC
-
SK Biopharm strikes $800m deal for epilepsy drug from Biohaven
SK Biopharm strikes $800m deal for epilepsy drug from Biohaven
-
Biohaven (BHVN) Stock Plummets After Pausing Midstage Seizure Treatment Study Due to Safety Concerns and FDA Toxicity Assessment Requirement
Biohaven (BHVN) stock plummeted Thursday after the company paused enrollment in a midstage study of its seizure treatment opakalim due to safety concerns. The Food and Drug Administration (FDA) is now
-
RBC Downgrades Biohaven to "Sector Perform," Lowers Price Target to $19; Biohaven Shares Down 1.9% in Pre-market Trading
Biohaven Pharmaceutical (NYSE:BHVN) shares fell 1.9% in premarket trading after RBC Capital downgraded the stock to "Sector Perform" from "Outperform" and lowered its price target to $19 from $23. RBC
-
SK Biopharm strikes $800m deal for epilepsy drug from Biohaven
SK Biopharm strikes $800m deal for epilepsy drug from Biohaven
- No data
Biohaven
24H Trending
-
1
Regulatory Landscape of Virtual Currencies in Mainland China and Risks Associated with Using Overseas Trading Platforms
-
2
SKR Tokenomics Analysis: The Core Driver of the Solana Mobile Ecosystem
-
3
According to Bloomberg Markets: Large asset managers are deleveraging in the U.S. Treasury futures market, triggered by forced selling as cash yields approach multi-year highs.
-
4
Wall Street's Rate Shock Spreads Beneath AI-Fueled Market Rally, Driven by High Oil Prices and Borrowing Costs
-
5
iPhone Vulnerabilities Continue to Threaten Crypto Users, Older iOS Devices Remain at Risk
-
6
TypeSafe AI, the maker of the non-text AI model Jev, reached a valuation of $7.5 billion just weeks after its launch, with a16z leading an $870 million funding round.
-
7
Hungary Needs Significant Deficit Cut For Euro Path, Magyar Says
-
8
Base Network: Coinbase's Layer 2 Solution and Its Ecosystem Development Status
-
9
Binance founder CZ warns of potential supply chain attack on Ledger hardware wallets, calls on BNB ecosystem to help recover funds.
-
10
Neo (Antcoin) In-depth Analysis: The Technical Evolution and Ecosystem Layout of "China's Ethereum"
Markets Today
Recommended Reading




